The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease - Test2 - elhamkhani - TriplyDB

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease

http://www.wikidata.org/entity/Q26781815

about

Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related Diseases An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition Interleukin-8 gene polymorphism -251T>A contributes to Alzheimer's disease susceptibility.Association between Metabolic Syndrome and Cognitive Impairment after Acute Ischemic Stroke: A Cross-Sectional Study in a Chinese Population.T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers.Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids.Natural Xanthones from Garcinia mangostana with Multifunctional Activities for the Therapy of Alzheimer's Disease.Antineuroinflammatory Effects of Modified Wu-Zi-Yan-Zong Prescription in β-Amyloid-Stimulated BV2 Microglia via the NF-κB and ERK/p38 MAPK Signaling Pathways.Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease.Resveratrol-based cinnamic ester hybrids: synthesis, characterization, and anti-inflammatory activity.Therapeutic effects of pegylated-interferon-α2a in a mouse model of multiple sclerosis.The role of inflammation in the development of epilepsy.Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.

P2860

Q26746303-11E8CD43-9667-4FCB-AC30-AEABBEA56473 Q26751302-2EEC86F2-62B5-4DB3-B0F3-63467DFEEB32 Q26771954-B028AA38-A02A-4FCA-B55C-6063FFC4364D Q36148155-91FFEA8D-B5F8-4A8D-8CC2-DF2E400434BC Q36218067-023CC039-A995-4383-A054-9C5D82688B65 Q37672845-66F21156-1326-48A8-BA10-09429A734BEF Q38774697-267BAF23-515B-4722-91FE-8F749659BD25 Q38781331-D749F40E-CA0F-430E-B9A9-3139BB91EE74 Q41180360-D2D9245A-6BA7-477D-A0A9-0DFC1A989DDB Q46455298-F5F765F8-AE16-4ABA-879B-27C4FB83B8AD Q47408910-63F5E88B-581F-40A7-975A-F457B13242C7 Q55054591-CC3E5997-FFB7-49F1-BF75-5ADB2594F001 Q55265934-29C87567-2EC5-412C-B75F-CB8199A344B7 Q55686847-D812B88E-C1E3-4D60-AA81-27B79293A826

P2860

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease

http://www.wikidata.org/entity/Q26781815

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease

@ast

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease

@en

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease

@nl

type

label

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease

@ast

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease

@en

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease

@nl

prefLabel

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease

@ast

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease

@en

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease

@nl

P1433

Q26781815-7B4EBA0B-F107-4A4E-9F37-D47BF2B3385D

P1476

Q26781815-185F401A-41AC-4E0D-8D18-A4E7F85BC74E

P2093

Q26781815-0EC4347E-740C-4C87-91E0-95B28688FD54

Q26781815-A1B249BF-B488-4FCA-8FB2-56F077010A1D

Q26781815-E17A4C0E-260C-4F46-A387-03952EB0894B

Q26781815-E916F20F-0771-4F6C-865C-879F2DE84911

P2860

Q26781815-000A13E9-6B61-4BC7-8A51-16F6825CBA78

Q26781815-029FE147-AD98-4718-8A9A-F5D431A9C328

Q26781815-044FD90B-086F-4253-B5F5-E7A4C019A998

Q26781815-05E44376-32CA-43D4-BEA2-264D4D62F7F4

Q26781815-06E35651-116F-4F1C-989A-4F83D4BA8735

Q26781815-08191CDA-E0C0-4525-88B1-EAC04A57C5C2

Q26781815-09F75EA1-3C47-41B6-AD7C-2D445D6456EA

Q26781815-0D94D2C7-17A6-4C1C-80AC-50DFF02C1A2E

Q26781815-0E0AB8CE-B483-4ED8-BD83-009370CFA872

Q26781815-0F96857B-E5BA-4A4C-BA91-FBB638DADCD3

P304

Q26781815-FE48BD9B-AFA5-42BA-B757-0AA6818BCF29

P31

Q26781815-1FE4C064-2A07-4FF1-91DC-CFB78B674534

P3181

Q26781815-55E7B8C7-C0B6-4298-848B-4DB87CBD4FD5

P356

Q26781815-C09D0A9F-0002-4E25-BF91-6BA06E0896AC

P407

Q26781815-6E423D15-64FA-4BD1-BB72-A670E1BC27CC

P433

Q26781815-5E9441E8-77E8-4355-95AC-3B6F360BA373

P478

Q26781815-D8FB2756-93C4-4BC9-A5D1-8ED0E3FA221B

P50

Q26781815-7086221F-0EB2-4D6F-B416-EAD56FE8A84E

Q26781815-8174F34E-B815-4AC0-8F81-CEA38A78AA9F

P577

Q26781815-AC4A4564-ADF2-4A9C-8E46-E75411795809

P5875

Q26781815-6B145CAA-1913-476D-8326-F2151463B85E

P698

Q26781815-D5A6D404-FD01-4F78-8A2B-E0C1CBDE66EC

P921

Q26781815-153F3462-0FED-450B-8817-D845D62B9514

Q26781815-27810A4A-F30E-465A-95A2-35764B7BAD52

Q26781815-498B1216-C931-43BF-BCA4-1A124EF72F54

P932

Q26781815-E3791FA2-3BB9-4631-83F6-2D31DF965B8E

P3181

P356

SQUMJ.2015.15.03.002

P1433

Sultan Qaboos University medical journal

P1476

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease

@en

P2093

Ahmed Al-Shukaili

http://www.w3.org/2001/XMLSchema#string

Mir H Seyedzadeh

http://www.w3.org/2001/XMLSchema#string

Reza Yazdani

http://www.w3.org/2001/XMLSchema#string

Shadi S Navabi

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer's Disease

Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease

Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.

The role of macrophage migration inhibitory factor in Alzheimer's disease

Immunotherapy for Alzheimer's disease: hoops and hurdles

Osteoporosis and alzheimer pathology: Role of cellular stress response and hormetic redox signaling in aging and bone remodeling

Neuropathological alterations in Alzheimer disease

The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis

CD4 T cells in immunity and immunotherapy of Alzheimer's disease

Inflammation and Alzheimer's disease

P304

e305-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

922800

http://www.w3.org/2001/XMLSchema#string

P356

10.18295/SQUMJ.2015.15.03.002

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Gholamreza Azizi

Abbas Mirshafiey

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281681449

http://www.w3.org/2001/XMLSchema#string

P698

26357550

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4554263

http://www.w3.org/2001/XMLSchema#string